AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. FCF margin (%)

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥198.9B
P/E ratio
71.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndFCF margin (%) YoY (%)
Mar 31, 202527.3+2643.77%
Mar 31, 20241-90.02%
Mar 31, 202310-26.86%
Mar 31, 202213.6-17.74%
Mar 31, 202116.5-41.66%
Mar 31, 202028.4+38.95%
Mar 31, 201920.4+0.39%
Mar 31, 201820.3+56.78%
Mar 31, 201713-40.56%
Mar 31, 201621.8+60.26%
Mar 31, 201513.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)